QUODD

Insider Transactions last 24 months for Adaptimmune Therapeutics PLC - NSDQ: ADAP

Transactions
All	Buy	Sell	Option Exercise

Filer's Name	Relationship/ Title	Trans. Date	Trans. Type	Ownership Type	Security Type	Shares	Price	Trans. Value	Total Shares Owned
Wood Gavin	Chief Financial Officer	09/02/2025	DS	Direct	COM	96,000	$0.01	$950.40	0
Bertrand William C Jr	Chief Operating Officer	08/28/2025	DS	Direct	COM	207,000	$0.01	$2,090.70	986,352
Behbahani Ali	Director	08/18/2025	DS	Indirect	COM	14,671,794	$0.01	$176,061.53	0
Behbahani Ali	Director	08/15/2025	DS	Indirect	COM	4,828,206	$0.01	$53,110.27	14,671,794
Ecor1 Capital, Llc	Other	07/30/2025	DS	Indirect	COM	27,433,338	$0.10	$2,800,943.81	100,371,882
Ecor1 Capital, Llc	Other	07/29/2025	DS	Indirect	COM	2,687,460	$0.10	$271,970.95	127,805,220
Ecor1 Capital, Llc	Other	07/28/2025	DS	Indirect	COM	33,931,740	$0.11	$3,817,320.75	130,492,680
Rawcliffe Adrian	Chief Executive Officer	01/17/2025	DS	Direct	COM	30,601	$0.58	$17,773.06	44,327
Bertrand William C Jr	Chief Operating Officer	01/17/2025	DS	Direct	COM	5,584	$0.58	$3,243.19	7,510
Lunger John	Chief Patient Supply Officer	01/17/2025	DS	Direct	COM	5,584	$0.58	$3,243.19	7,510
Norry Elliot	Chief Medical Officer	01/17/2025	DS	Direct	COM	5,584	$0.58	$3,243.19	7,510
Bertrand William C Jr	Chief Operating Officer	01/15/2025	DS	Direct	COM	9,803	$0.57	$5,634.76	13,756
Lunger John	Chief Patient Supply Officer	01/15/2025	DS	Direct	COM	9,803	$0.57	$5,634.76	13,756
Norry Elliot	Chief Medical Officer	01/15/2025	DS	Direct	COM	9,803	$0.57	$5,634.76	13,756
Piccina Cintia	Chief Commercial Officer	01/15/2025	DS	Direct	COM	12,991	$0.57	$7,467.23	18,421
Rawcliffe Adrian	Chief Executive Officer	01/15/2025	DS	Direct	COM	29,096	$0.57	$16,724.38	41,582
Bertrand William C Jr	Chief Operating Officer	01/13/2025	DS	Direct	COM	5,471	$0.59	$3,216.40	7,623
Bertrand William C Jr	Chief Operating Officer	01/13/2025	DS	Direct	COM	4,268	$0.59	$2,509.16	5,845
Lunger John	Chief Patient Supply Officer	01/13/2025	DS	Direct	COM	5,471	$0.59	$3,216.40	7,623
Lunger John	Chief Patient Supply Officer	01/13/2025	DS	Direct	COM	4,268	$0.59	$2,509.16	5,845
Norry Elliot	Chief Medical Officer	01/13/2025	DS	Direct	COM	8,124	$0.59	$4,776.10	11,516
Norry Elliot	Chief Medical Officer	01/13/2025	DS	Direct	COM	4,268	$0.59	$2,509.16	5,845
Rawcliffe Adrian	Chief Executive Officer	01/13/2025	DS	Direct	COM	17,934	$0.59	$10,543.40	25,711
Rawcliffe Adrian	Chief Executive Officer	01/13/2025	DS	Direct	COM	12,539	$0.59	$7,371.68	17,801
Piccina Cintia	Chief Commercial Officer	06/18/2024	DS	Direct	COM	24,531	$0.93	$22,813.83	38,293

1 2 Next Last You are at page 1 of 2 pages

Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security \| D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) \| E = Expiration of short derivative position \| F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. \| G = Gift \| H = Expiration (or cancellation) of long derivative position with value received \| I = Discretionary transaction in accordance with Rule 16b-3(f) \| J = Other \| L = Small acquisition under Rule 16a-6 \| M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 \| O = Exercise of out-of-the-money derivative security \| P = Open market or private purchase \| S = Open market or private sale \| U = Disposition pursuant to a tender of shares in a change of control transaction \| W = Acquisition or disposition by will or the laws of descent and distribution \| X = Exercise of in-the-money or at-the-money derivative security \| Z = Deposit into or withdrawal from voting trust		Send to Excel

Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust

Send to Excel